Mustang Bio (MBIO) vs PRF Technologies (PRFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Mustang Bio is the larger company by market cap ($3.3 million vs $3.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MBIO | PRFX |
|---|---|---|
| Share price | $0.4345 | $0.8667 |
| Market cap | $3.29M | $3.03M |
| 1-day change | -3.49% | -1.25% |
| EPS (TTM) | $-0.44 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.85 | $7.95 |
| 52-week low | $0.425 | $0.852 |
| Distance from 52-week high | -76.51% | -89.10% |
| Average volume | 29.24K | 298.86K |
| Shares outstanding | 6.73M | 3.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MBIO vs PRFX FAQ
Which is bigger, Mustang Bio or PRF Technologies?
Mustang Bio (MBIO) is larger, with a market capitalization of $3.29M compared with $3.03M for PRF Technologies (PRFX).
Are Mustang Bio and PRF Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.